Hakutulokset - Lleo, Alberto

Current Therapeutic Options for Alzheimer’s Disease Tekijä Lleó, Alberto

Hae kokoteksti Hae kokoteksti Hae kokoteksti

Biomarkers in neurological disorders: a fast-growing market Tekijä Lleó, Alberto

Hae kokoteksti Hae kokoteksti Hae kokoteksti

The cognitive aftermath of COVID-19 Tekijä Lleó, Alberto, Alcolea, Daniel

Hae kokoteksti Hae kokoteksti

Race and Alzheimer Disease Biomarkers: A Neglected Race Tekijä Lleó, Alberto, Suárez-Calvet, Marc

Hae kokoteksti Hae kokoteksti Hae kokoteksti

Decreased CX3CL1 Levels in the Cerebrospinal Fluid of Patients With Alzheimer’s Disease Tekijä Perea, Juan R., Lleó, Alberto, Alcolea, Daniel, Fortea, Juan, Ávila, Jesús, Bolós, Marta

Hae kokoteksti Hae kokoteksti Hae kokoteksti

Familial Alzheimer's Disease Presenilin 1 Mutations Cause Alterations in the Conformation of Presenilin and Interactions with Amyloid Precursor Protein Tekijä Berezovska, Oksana, Lleo, Alberto, Herl, Lauren D., Frosch, Matthew P., Stern, Edward A., Bacskai, Brian J., Hyman, Bradley T.

Hae kokoteksti Hae kokoteksti Hae kokoteksti

Dense core vesicle markers in CSF and cortical tissues of patients with Alzheimer’s disease Tekijä Barranco, Neus, Plá, Virginia, Alcolea, Daniel, Sánchez-Domínguez, Irene, Fischer-Colbrie, Reiner, Ferrer, Isidro, Lleó, Alberto, Aguado, Fernando

Hae kokoteksti Hae kokoteksti Hae kokoteksti

The Proton-Pump Inhibitor Lansoprazole Enhances Amyloid Beta Production Tekijä Badiola, Nahuai, Alcalde, Victor, Pujol, Albert, Münter, Lisa-Marie, Multhaup, Gerd, Lleó, Alberto, Coma, Mireia, Soler-López, Montserrat, Aloy, Patrick

Hae kokoteksti Hae kokoteksti Hae kokoteksti

Cerebrospinal fluid Presenilin-1 increases at asymptomatic stage in genetically determined Alzheimer’s disease Tekijä Sogorb-Esteve, Aitana, García-Ayllón, María-Salud, Fortea, Juan, Sánchez-Valle, Raquel, Lleó, Alberto, Molinuevo, José-Luis, Sáez-Valero, Javier

Hae kokoteksti Hae kokoteksti Hae kokoteksti

YKL-40 (Chitinase 3-like I) is expressed in a subset of astrocytes in Alzheimer’s disease and other tauopathies Tekijä Querol-Vilaseca, Marta, Colom-Cadena, Martí, Pegueroles, Jordi, San Martín-Paniello, Carla, Clarimon, Jordi, Belbin, Olivia, Fortea, Juan, Lleó, Alberto

Hae kokoteksti Hae kokoteksti Hae kokoteksti

Cortical microstructural correlates of astrocytosis in autosomal-dominant Alzheimer disease Tekijä Vilaplana, Eduard, Rodriguez-Vieitez, Elena, Ferreira, Daniel, Montal, Victor, Almkvist, Ove, Wall, Anders, Lleó, Alberto, Westman, Eric, Graff, Caroline, Fortea, Juan, Nordberg, Agneta

Hae kokoteksti Hae kokoteksti Hae kokoteksti

Nerve growth factor (NGF) pathway biomarkers in Down syndrome prior to and after the onset of clinical Alzheimer's disease: A paired CSF and plasma study Tekijä Pentz, Rowan, Iulita, M. Florencia, Ducatenzeiler, Adriana, Videla, Laura, Benejam, Bessy, Carmona‐Iragui, María, Blesa, Rafael, Lleó, Alberto, Fortea, Juan, Cuello, A. Claudio

Hae kokoteksti Hae kokoteksti Hae kokoteksti

Increased plasma neurofilament light chain levels in patients with type-1 diabetes with impaired awareness of hypoglycemia Tekijä Sampedro, Frederic, Stantonyonge, Nicole, Martínez-Horta, Saül, Alcolea, Daniel, Lleó, Alberto, Muñoz, Laia, Pérez-González, Rocío, Marín-Lahoz, Juan, Gómez-Ansón, Beatriz, Chico, Ana

Hae kokoteksti Hae kokoteksti Hae kokoteksti

Tau Enhances α-Synuclein Aggregation and Toxicity in Cellular Models of Synucleinopathy Tekijä Badiola, Nahuai, de Oliveira, Rita Machado, Herrera, Federico, Guardia-Laguarta, Cristina, Gonçalves, Susana A., Pera, Marta, Suárez-Calvet, Marc, Clarimon, Jordi, Outeiro, Tiago Fleming, Lleó, Alberto

Hae kokoteksti Hae kokoteksti Hae kokoteksti

Exome sequencing in a consanguineous family clinically diagnosed with early onset Alzheimer’s disease identifies an homozygous CTSF mutation Tekijä Bras, Jose, Djaldetti, Ruth, Alves, Ana Margarida, Mead, Simon, Darwent, Lee, Lleo, Alberto, Molinuevo, Jose Luis, Blesa, Rafael, Singleton, Andrew, Hardy, John, Clarimon, Jordi, Guerreiro, Rita

Hae kokoteksti Hae kokoteksti Hae kokoteksti

Altered microRNAs related to synaptic function as potential plasma biomarkers for Alzheimer’s disease Tekijä Siedlecki-Wullich, Dolores, Català-Solsona, Judit, Fábregas, Cristina, Hernández, Isabel, Clarimon, Jordi, Lleó, Alberto, Boada, Merce, Saura, Carlos A., Rodríguez-Álvarez, José, Miñano-Molina, Alfredo J.

Hae kokoteksti Hae kokoteksti Hae kokoteksti

β-Amyloid Disrupts Activity-Dependent Gene Transcription Required for Memory through the CREB Coactivator CRTC1 Tekijä España, Judit, Valero, Jorge, Miñano-Molina, Alfredo J., Masgrau, Roser, Martín, Elsa, Guardia-Laguarta, Cristina, Lleó, Alberto, Giménez-Llort, Lydia, Rodríguez-Alvarez, José, Saura, Carlos A.

Hae kokoteksti Hae kokoteksti Hae kokoteksti

AMYQ: An index to standardize quantitative amyloid load across PET tracers Tekijä Pegueroles, Jordi, Montal, Victor, Bejanin, Alexandre, Vilaplana, Eduard, Aranha, Mateus, Santos‐Santos, Miguel Angel, Alcolea, Daniel, Carrió, Ignasi, Camacho, Valle, Blesa, Rafael, Lleó, Alberto, Fortea, Juan

Hae kokoteksti Hae kokoteksti Hae kokoteksti

Blood amyloid and tau biomarkers as predictors of cerebrospinal fluid profiles Tekijä Delaby, Constance, Alcolea, Daniel, Hirtz, Christophe, Vialaret, Jérôme, Kindermans, Jana, Morichon, Lisa, Fortea, Juan, Belbin, Olivia, Gabelle, Audrey, Blennow, Kaj, Zetterberg, Henrik, Lleó, Alberto, Lehmann, Sylvain

Hae kokoteksti Hae kokoteksti Hae kokoteksti

C-terminal fragments of the amyloid precursor protein in cerebrospinal fluid as potential biomarkers for Alzheimer disease Tekijä García-Ayllón, María-Salud, Lopez-Font, Inmaculada, Boix, Claudia P., Fortea, Juan, Sánchez-Valle, Raquel, Lleó, Alberto, Molinuevo, José-Luis, Zetterberg, Henrik, Blennow, Kaj, Sáez-Valero, Javier

Hae kokoteksti Hae kokoteksti Hae kokoteksti